Home
> Mark Levis

Mark Levis

Mark Levis

BiomedExperts Profile

Help us refine your profile

Profile

Trends

Research Network

Publications

1.
2013

A B Williams; B Nguyen; L Li; P Brown; M Levis; D Leahy; D Small

Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors.
Leukemia 2013;27(1):48-55.
2.
2012

Judith E Karp; Brian M Thomas; Jacqueline M Greer; Christopher Sorge; Steven D Gore; Keith W Pratz; B Douglas Smith; Karen S Flatten; Kevin Peterson; Paula Schneider; et al.

Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(24):6723-31.
3.
2012

Amy Sexauer; Alexander Perl; Xiaochuan Yang; Michael Borowitz; Christopher Gocke; Trivikram Rajkhowa; Christian Thiede; Mark Frattini; Grant E Nybakken; Keith Pratz; et al.

Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML.
Blood 2012;120(20):4205-14.

Similar Experts

Publications
Donald Small

84
B Smith

112
Judith Karp

232
Patrick Brown

30
Steven Gore

136

Journals

Publications
Blood

27
Leukemia

6
British journal of h...

4
Clinical cancer rese...

4
Leukemia & lymphoma

2

Coauthor Network

Internal Coauthors

Shared Pub.
Donald Small

33
B Smith

24
Judith Karp

18
Steven Gore

12
Keith Pratz

11
Patrick Brown

9

External Coauthors

Shared Pub.
A MICHAEL MCDEVITT

9
Hetty Carraway

7
Kyu-Tae Kim

6
Obdulio Piloto

6
Li Li

6
John J Wright

5